3-sulfonyl-3,7-diazabicyclo[3,3,1]nonane compounds and medicamen

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514278, 546 18, 546122, A61K 3144, C07D47108

Patent

active

049066404

ABSTRACT:
3-sulfonyl-3,7-diazabicyclo[3,3,1]nonane compounds corresponding to the formula: ##STR1## wherein R.sup.1 is alkyl, cycloalkylalkyl or benzyl,

REFERENCES:
patent: 3962449 (1976-06-01), Binnig et al.
patent: 4183935 (1980-01-01), Binnig et al.
patent: 4459301 (1984-06-01), Binnig et al.
patent: 4550112 (1985-10-01), Schoen et al.
patent: 4771044 (1988-09-01), Schoen et al.
Fieser and Fieser, Advanced Organic Chem., Reinhold Pub., p. 699, (1961).
Hoerlein, Eur. J. Med. Chem., 12, No. 4, pp. 301-305, (1977).
Hoerlein et al., "Ueber unsymmetrisch N-substituierte Bispidine (3,7-Diazabicyclo[3.3.1]nonane, II", Chemische Berichte, vol. 110, pp. 3894-3899, (1977).
Chemical Abstracts, vol. 87, No. 25, p. 727, 201499q, (1977).
Chemical Abstracts, vol. 88, No. 5, p. 484, 37592n, (1978).
Chemical Abstracts, vol. 76, No. 25, p. 408, 153122k, (1972).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3-sulfonyl-3,7-diazabicyclo[3,3,1]nonane compounds and medicamen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-sulfonyl-3,7-diazabicyclo[3,3,1]nonane compounds and medicamen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-sulfonyl-3,7-diazabicyclo[3,3,1]nonane compounds and medicamen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-47669

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.